The EAAT1 aspartate/glutamate transporter is dispensable for acute myeloid leukemia cell growth and response to therapy
Hernán A. Tirado, Nithya Balasundaram, Jean Jacobs, Fleur Leguay, Lotfi Laaouimir, Nick van Gastel
This study investigates the role of EAAT1 in AML cell growth and therapy response, finding that EAAT1 inhibition does not impair AML growth or chemosensitivity.
PLoS ONE · Feb 24, 2026Peer-reviewedCancer Biology